Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Phio Pharmaceuticals Gelecekteki Büyüme
Future kriter kontrolleri 5/6
Phio Pharmaceuticals is forecast to grow earnings and revenue by 183.3% and 213.8% per annum respectively while EPS is expected to grow by 162% per annum.
Anahtar bilgiler
183.3%
Kazanç büyüme oranı
162.0%
EPS büyüme oranı
Biotechs kazanç büyümesi | 28.6% |
Gelir büyüme oranı | 213.8% |
Gelecekteki özkaynak getirisi | n/a |
Analist kapsamı | Low |
Son güncelleme | 14 May 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Phio Pharmaceuticals appoints interim executive chairman
Sep 29Phio Pharmaceuticals GAAP EPS of -$0.19 beats by $0.12
Aug 11Is Phio Pharmaceuticals (NASDAQ:PHIO) In A Good Position To Deliver On Growth Plans?
Apr 11Phio soars 22% on positive in vivo data on combination PD-1 and TIGIT therapy in cancer
Nov 09Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
12/31/2025 | 75 | 48 | N/A | N/A | 1 |
12/31/2024 | N/A | -10 | N/A | N/A | 1 |
6/30/2024 | N/A | -9 | -9 | -9 | N/A |
3/31/2024 | N/A | -9 | -10 | -10 | N/A |
12/31/2023 | N/A | -11 | -11 | -11 | N/A |
9/30/2023 | N/A | -12 | -11 | -11 | N/A |
6/30/2023 | N/A | -12 | -12 | -12 | N/A |
3/31/2023 | N/A | -12 | -11 | -11 | N/A |
12/31/2022 | N/A | -11 | -12 | -12 | N/A |
9/30/2022 | N/A | -12 | -12 | -12 | N/A |
6/30/2022 | N/A | -12 | -11 | -11 | N/A |
3/31/2022 | N/A | -13 | -12 | -12 | N/A |
12/31/2021 | N/A | -13 | -12 | -12 | N/A |
9/30/2021 | N/A | -12 | -12 | -12 | N/A |
6/30/2021 | N/A | -11 | -11 | -11 | N/A |
3/31/2021 | N/A | -10 | -10 | -10 | N/A |
12/31/2020 | N/A | -9 | -9 | -9 | N/A |
9/30/2020 | N/A | -9 | -9 | -9 | N/A |
6/30/2020 | N/A | -9 | -9 | -9 | N/A |
3/31/2020 | N/A | -9 | -9 | -9 | N/A |
12/31/2019 | 0 | -9 | -9 | -9 | N/A |
9/30/2019 | 0 | -8 | -8 | -8 | N/A |
6/30/2019 | 0 | -7 | -8 | -8 | N/A |
3/31/2019 | 0 | -7 | -8 | -8 | N/A |
12/31/2018 | 0 | -7 | -8 | -8 | N/A |
9/30/2018 | 0 | -8 | -8 | -8 | N/A |
6/30/2018 | 0 | -9 | -8 | -8 | N/A |
3/31/2018 | 0 | -9 | N/A | -9 | N/A |
12/31/2017 | 0 | -12 | N/A | -10 | N/A |
9/30/2017 | N/A | -15 | N/A | -9 | N/A |
6/30/2017 | N/A | -15 | N/A | -8 | N/A |
3/31/2017 | 0 | -14 | N/A | -8 | N/A |
12/31/2016 | 0 | -11 | N/A | -8 | N/A |
9/30/2016 | 0 | -9 | N/A | -8 | N/A |
6/30/2016 | 0 | -10 | N/A | -8 | N/A |
3/31/2016 | 0 | -10 | N/A | -8 | N/A |
12/31/2015 | 0 | -10 | N/A | -7 | N/A |
9/30/2015 | 0 | -11 | N/A | -7 | N/A |
6/30/2015 | 0 | -11 | N/A | -7 | N/A |
3/31/2015 | 0 | -12 | N/A | -7 | N/A |
12/31/2014 | 0 | -13 | N/A | -8 | N/A |
9/30/2014 | 0 | -14 | N/A | -8 | N/A |
6/30/2014 | 0 | -14 | N/A | -8 | N/A |
3/31/2014 | 0 | -16 | N/A | -8 | N/A |
12/31/2013 | 0 | -30 | N/A | -6 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: PHIO is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).
Kazançlar ve Piyasa: PHIO is forecast to become profitable over the next 3 years, which is considered above average market growth.
Yüksek Büyüme Kazançları: PHIO is expected to become profitable in the next 3 years.
Gelir ve Pazar: PHIO's revenue (213.8% per year) is forecast to grow faster than the US market (8.7% per year).
Yüksek Büyüme Geliri: PHIO's revenue (213.8% per year) is forecast to grow faster than 20% per year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: Insufficient data to determine if PHIO's Return on Equity is forecast to be high in 3 years time